⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 18 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 18 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 28, 2026

Amlodipin/Valsartan/HCT 1A Pharma 10 mg/160 mg/12,5 mg – Filmtabletten 10/160/12,5 mg (Filmtablette)

📷 Wikipedia: Amlodipine · Source
Amlodipin/Valsartan/HCT 1A Pharma 10 mg/160 mg/12,5 mg – Filmtabletten 10/160/12,5 mg (Filmtablette)
📷 Wikipedia: Amlodipine · Source
Amlodipine/Valsartan/HCT 1A Pharma 10 mg/160 mg/12.5 mg – film-coated tablets (10/160/12.5 mg per tablet) Parallel export is banned. Shortage due to manufacturing capacity issues. Affected packs: 28-tablet box, blister pack. Unavailable since 28 April 2026.
⚠️
Shortage ongoing
AMLODIPIN BESILAT is currently in short supply in AT.
📈 Timeline
34 days active so far
May 18, 2026 June 20, 2026

What is this? This is a blood-pressure pill that mixes three medicines: amlodipine, valsartan and hydrochlorothiazide.

What's happening? The maker cannot make enough of these pills right now, so they are out of stock.

Does this affect me? If your doctor has prescribed this exact pill, you may not be able to get it at the pharmacy.

What should I do? Ask your pharmacist or doctor for another blood-pressure pill that is in stock.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: C09DX01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-28]

First published
April 28, 2026
Last refreshed by us
1 month ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 6 days ago

Valsartan/HCT 1A Pharma 160 mg/12,5 mg - Filmtabletten 160 mg/12,5 mg (Filmtablette)

Valsartan/HCT 1A Pharma 160 mg/12.5 mg film-coated tablets are unavailable due to manufacturing capacity issues.
High AT 1 week ago

Candecam 8 mg/5 mg Tabletten 8/5 mg/mg (Tablette)

ATC: C09DB07 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: HCS B.V., Hendrik Kennisstraat 53, 2650 Edegem, Kingdom of Belgium · Affected packs: 28 Stück Schachtel, Bliste...
High AT 1 week ago

Lisinopril-HCT ratiopharm - Tabletten (Tablette)

🚫 Parallel export ban active · ATC: C09BA03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück...
High AT 1 week ago

Ramipril-HCT ratiopharm 2,5 mg/ 12,5 mg - Tabletten 2,5 mg/12,5 mg (Tablette)

ATC: C09BA05 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
High AT 1 week ago

Amlodipin/Valsartan/Hydrochlorothiazid ratiopharm 5 mg/160 mg/12,5 mg Filmtabletten 5/160/12,5 mg (Filmtablette)

ATC: C09DX01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
High AT 2 weeks ago

Amlodipin/Valsartan/HCT Sandoz 5 mg/160 mg/25 mg – Filmtabletten 5/160/25 mg (Filmtablette)

Parallel export is banned for this medicine. It is unavailable due to manufacturing capacity shortages.
High AT 2 weeks ago

Amlodipin/Valsartan Actavis 5 mg/80 mg Filmtabletten 5/80 mg/mg (Filmtablette)

Amlodipine/Valsartan Actavis 5 mg/80 mg film-coated tablets are delayed in production.
High AT 3 weeks ago

Amlodipin/Valsartan 1A Pharma 5 mg/80 mg - Filmtabletten 5 mg/80 mg mg/mg (Filmtablette)

Amlodipine/Valsartan 1A Pharma 5 mg/80 mg film-coated tablets are unavailable due to manufacturing capacity issues.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Amlodipin/Valsartan/HCT 1A Pharma 10 mg/160 mg/12,5 mg – Filmtabletten 10/160/12,5 mg (Filmtablette). Amlodipine/Valsartan/HCT 1A Pharma 10 mg/160 mg/12.5 mg – film-coated tablets (10/160/12.5 mg per tablet) Parallel export is banned. Shortage due to manufacturing capacity issues. Affected packs: 28-tablet box, blister pack. Unavailable since 28 April 2026.
▸ When was this alert issued?
This alert was issued on April 28, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.